支气管哮喘缓解期中医药治疗的适宜性技术筛选研究

Screening and Evaluation on Feasibility of Traditional Chinese Medicine for Remission Phase of Bronchial Asthma

目的:针对支气管哮喘缓解期,采用文献学方法,筛选评价中医药治疗的适宜性技术,以期指导临床医师使用。方法:检索中国知网数据库、维普期刊资源整合服务平台、万方数据库、中国生物医学文献服务系统的期刊文献,纳入所有中医药治疗支气管哮喘缓解期的临床研究。基于中医农村适宜技术筛选评价指标体系,提取评估指标并进行评价。结果:共筛选得到150个治疗技术,主要为中药复方和穴位贴敷组成。评分分布在24.857至34.304之间,筛选评分最高的为治疗哮喘缓解期肺肾两虚的补肺颗粒。结论:初步筛选补肺颗粒、玉屏风散、邵氏阳虚哮喘贴等20项中医药治疗哮喘缓解期的适宜技术,可在基层推广应用。

To screen and evaluate the TCM in the treatment of bronchial asthma. Methods Retrieved the journals from China National Knowledge Infrastructure, the Vip Database, Wanfang Data and the Chinese Biomedical Literature Database（Sino Med）. The time limitation ran from January 1, 1987 to December 31, 2016. Extracted the indicators of the assessment based on the evaluating and screening system of country feasible TCM technology. Results a total of 150 treatment techniques were screened.They mostly were Chinese compound formula or point-application therapy. The score was between 24.857 and 34.304. Application of evaluating and screening system of country feasible TCM technology can screen and evaluate the feasible technologiesin the treatment of remission phase of bronchial asthma.